ID
int64 1
9.11k
| age
float64 18
102
| death
int64 0
1
| sex
stringclasses 2
values | hospdead
int64 0
1
| slos
int64 3
343
| d.time
int64 3
2.03k
| dzgroup
stringclasses 8
values | dzclass
stringclasses 4
values | num.co
int64 0
9
| edu
float64 0
31
⌀ | income
stringclasses 4
values | scoma
float64 0
100
⌀ | charges
float64 1.17k
1.44M
⌀ | totcst
float64 0
633k
⌀ | totmcst
float64 -102.72
711k
⌀ | avtisst
float64 1
83
⌀ | race
stringclasses 5
values | sps
float64 0.2
99.2
⌀ | aps
float64 0
143
⌀ | surv2m
float64 0
0.97
⌀ | surv6m
float64 0
0.95
⌀ | hday
int64 1
148
| diabetes
int64 0
1
| dementia
int64 0
1
| ca
stringclasses 3
values | prg2m
float64 0
1
⌀ | prg6m
float64 0
1
⌀ | dnr
stringclasses 3
values | dnrday
float64 -88
285
⌀ | meanbp
float64 0
195
⌀ | wblc
float64 0
200
⌀ | hrt
float64 0
300
⌀ | resp
float64 0
90
⌀ | temp
float64 31.7
41.7
⌀ | pafi
float64 12
890
⌀ | alb
float64 0.4
29
⌀ | bili
float64 0.1
63
⌀ | crea
float64 0.1
21.5
⌀ | sod
float64 110
181
⌀ | ph
float64 6.83
7.77
⌀ | glucose
float64 0
1.09k
⌀ | bun
float64 1
300
⌀ | urine
float64 0
9k
⌀ | adlp
float64 0
7
⌀ | adls
float64 0
7
⌀ | sfdm2
stringclasses 5
values | adlsc
float64 0
7.07
|
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1,201 | 67.52899 | 1 | male | 0 | 3 | 533 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 9,941 | 3,885.0234 | 4,264.59766 | 6 | other | 16.699219 | 8 | 0.886963 | 0.810913 | 1 | 0 | 0 | no | null | null | no dnr | 3 | 102 | 6.099609 | 70 | 24 | 36.5 | 202.03125 | null | null | 1.399902 | 139 | 7.359375 | 162 | 15 | null | 2 | 7 | null | 7 |
1,202 | 43.06097 | 0 | male | 0 | 81 | 741 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 26 | 727,548 | 204,734.375 | 189,351.5 | 39.5 | hispanic | 27.898438 | 41 | 0.669922 | 0.573975 | 25 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 81 | 65 | 6.099609 | 135 | 28 | 37.79688 | 132.5 | null | 1.099854 | 1.199951 | 134 | 7.509766 | 145 | 31 | 4,425 | null | null | adl>=4 (>=5 if sur) | 2.947266 |
1,203 | 23.17 | 0 | male | 0 | 9 | 728 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 14 | >$50k | 0 | 26,594 | 9,269.4141 | 8,112.03906 | 10 | black | 24 | 18 | 0.901978 | 0.866943 | 2 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 9 | 103 | 22 | 96 | 28 | 38 | 155.09375 | null | null | 0.799927 | 133 | 7.40918 | null | 8 | 2,900 | 0 | 0 | null | 0 |
1,204 | 84.99896 | 0 | male | 0 | 7 | 728 | MOSF w/Malig | ARF/MOSF | 2 | 18 | null | 0 | 18,968 | 8,118.8359 | 8,390.15625 | 7 | white | 29.597656 | 46 | 0.531982 | 0.416992 | 1 | 1 | 0 | yes | 0.8 | 0.6 | no dnr | 7 | 75 | 8.398438 | 64 | 22 | 36.39844 | 108.15625 | null | null | 4.099609 | 134 | 7.15918 | 276 | 61 | 1,200 | 0 | null | null | 0.494751 |
1,205 | 52.88397 | 0 | male | 0 | 12 | 727 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 19 | >$50k | 9 | 34,829 | 15,494.9688 | 16,404.7969 | 24.5 | white | 34.296875 | 57 | 0.640991 | 0.53894 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 12 | 72 | 21.796875 | 75 | 28 | 37.5 | 140.8125 | 2.5 | 8.199219 | 2.399902 | 132 | 7.429688 | 108 | 58 | 3,460 | null | 2 | no(M2 and SIP pres) | 2 |
1,206 | 56.57498 | 0 | male | 0 | 13 | 727 | CHF | COPD/CHF/Cirrhosis | 2 | 16 | $11-$25k | 0 | 120,213 | 66,801.75 | 54,591.4062 | 31.5 | asian | 23.898438 | 29 | 0.843994 | 0.74292 | 1 | 0 | 0 | no | null | null | no dnr | 13 | 49 | 4.599609 | 65 | 20 | 36.19531 | null | null | 1.599854 | 1 | 134 | null | null | 24 | 2,950 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,207 | 59.02499 | 1 | male | 0 | 12 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | $11-$25k | 26 | 84,586 | 29,856.8594 | 30,643.25 | 36 | white | 28 | 61 | 0.680908 | 0.587891 | 1 | 1 | 0 | no | 0.6 | 0.5 | no dnr | 12 | 68 | 5.199219 | 110 | 8 | 36.39844 | 274.25 | 3.299805 | 2.399902 | 6.399414 | 142 | 7.549805 | 424 | 76 | 255 | null | 7 | <2 mo. follow-up | 7 |
1,208 | 35.379 | 0 | female | 0 | 8 | 725 | Colon Cancer | Cancer | 1 | 18 | >$50k | 0 | 30,835 | null | null | 19 | white | 7.599609 | 18 | 0.93396 | 0.844971 | 1 | 0 | 0 | metastatic | 1 | 0.99 | no dnr | 8 | 78 | 7.199219 | 120 | 22 | 39.19531 | null | 2.599609 | 0.199982 | 0.899902 | 139 | null | 79 | 14 | 3,730 | 0 | 0 | null | 0 |
1,209 | 50.59799 | 0 | male | 0 | 22 | 723 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 14 | $11-$25k | 44 | 178,970 | 49,564.5312 | 43,952.8125 | 29.666656 | white | 26.5 | 34 | 0.55188 | 0.438965 | 6 | 0 | 0 | yes | 1 | 0.9 | no dnr | 22 | 128 | 19.699219 | 55 | 14 | 38.59375 | 88.625 | null | null | 1.099854 | 148 | 7.529297 | 151 | 32 | 3,755 | null | null | adl>=4 (>=5 if sur) | 2.915039 |
1,210 | 39.52399 | 0 | male | 0 | 4 | 723 | CHF | COPD/CHF/Cirrhosis | 2 | 11 | null | 0 | 8,793 | 4,615.7695 | 4,074.4082 | 13 | black | 22.398438 | 23 | 0.901978 | 0.835938 | 1 | 0 | 0 | no | 0.95 | 0.8 | no dnr | 4 | 72 | 4.399414 | 115 | 20 | 36.09375 | null | null | null | 1.399902 | 132 | null | 82 | 22 | 5,620 | null | null | null | 2.23584 |
1,211 | 51.702 | 0 | female | 0 | 34 | 721 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | $25-$50k | 44 | 203,761 | 74,729.25 | 69,206.125 | 39.25 | white | 26.5 | 47 | 0.68396 | 0.590942 | 1 | 1 | 0 | no | 0.9 | 0.9 | no dnr | 34 | 62 | 10.099609 | 125 | 43 | 38.69531 | 154 | 2.799805 | null | 1.099854 | 146 | 7.469727 | 389 | 20 | 2,220 | null | 1 | null | 1 |
1,212 | 74.74896 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 8 | under $11k | 89 | 71,884 | 26,060.8906 | 28,643.4062 | 33.5 | hispanic | 30 | 77 | 0.222992 | 0.125 | 1 | 1 | 0 | no | 0.2 | 0.1 | dnr after sadm | 3 | 50 | 11.5 | 50 | 15 | 39 | 308 | null | 0.299988 | 6.699219 | 135 | 7.259766 | 238 | 53 | 0 | null | 0 | <2 mo. follow-up | 0 |
1,213 | 68.43799 | 1 | male | 0 | 7 | 108 | MOSF w/Malig | ARF/MOSF | 1 | 15 | >$50k | 0 | 22,713 | 10,020.3984 | 10,020.2969 | 10.5 | white | 20 | 19 | 0.712891 | 0.625977 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | no dnr | 7 | 68 | 9.5 | 75 | 22 | 38.59375 | 130 | null | null | 1.099854 | 133 | 7.439453 | 173 | 19 | 2,825 | 0 | 0 | null | 0 |
1,214 | 26.754 | 0 | female | 0 | 17 | 720 | Coma | Coma | 0 | null | null | 44 | 97,238 | 41,404.5312 | 49,768.375 | 28 | other | 20.699219 | 27 | 0.833984 | 0.800903 | 1 | 0 | 0 | no | 0.7 | 0.4 | no dnr | 17 | 103 | 16.5 | 115 | 12 | 38 | 445.6875 | null | null | 0.599976 | 141 | 7.569336 | 99 | 22 | 1,435 | null | null | null | 1.961182 |
1,215 | 68.60797 | 1 | female | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | null | 89 | 98,679 | 21,394.1875 | 24,554.8438 | 55 | white | 39.898438 | 89 | 0.025997 | 0.006 | 5 | 1 | 0 | no | 0 | 0 | dnr after sadm | 4 | 52 | 15.898438 | 80 | 26 | 36.89844 | 108.5625 | 2.599609 | 8.699219 | 2.299805 | 142 | 7.439453 | 364 | 43 | 0 | null | 0 | <2 mo. follow-up | 0 |
1,216 | 54.61697 | 1 | female | 0 | 28 | 312 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 12 | null | 26 | 144,291 | 53,110.9062 | 56,445.8438 | 22.75 | white | 27.398438 | 54 | 0.653931 | 0.554932 | 1 | 1 | 0 | yes | 0.9 | 0.9 | no dnr | 28 | 57 | 19.898438 | 110 | 6 | 39.09375 | 222.84375 | null | null | 6.199219 | 142 | 7.429688 | 96 | 36 | 5 | 5 | null | null | 3.854981 |
1,217 | 91.12695 | 0 | female | 0 | 7 | 717 | CHF | COPD/CHF/Cirrhosis | 2 | 17 | $11-$25k | 0 | 13,810 | 6,750.1758 | 7,777.64844 | 11 | white | 12.599609 | 11 | 0.86499 | 0.775879 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 7 | 104 | 5.299805 | 82 | 20 | 37.59375 | null | null | null | 1 | 140 | null | null | 19 | 2,705 | 0 | 0 | no(M2 and SIP pres) | 0 |
1,218 | 75.047 | 1 | female | 1 | 5 | 5 | Cirrhosis | COPD/CHF/Cirrhosis | 4 | null | null | 37 | 32,043 | 12,441.5078 | 16,372.6484 | 36 | white | 22.796875 | 29 | 0.454956 | 0.253967 | 1 | 0 | 0 | no | 0.7 | 0.6 | no dnr | 5 | 103 | 7.5 | 75 | 40 | 38.19531 | 740 | 2.699707 | 4 | 0.599976 | 129 | 7.329102 | 323 | 7 | 2,730 | null | 6 | <2 mo. follow-up | 6 |
1,219 | 65.29999 | 1 | male | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 12 | null | 26 | 267,914 | 78,850.4375 | 79,600.25 | 42.666657 | white | 40.796875 | 52 | 0.07399 | 0.026997 | 9 | 1 | 0 | metastatic | 0.5 | 0.5 | dnr after sadm | 21 | 43 | 3.299805 | 115 | 10 | 38 | 174.53125 | 2.799805 | 0.699951 | 7.199219 | 142 | 7.489258 | 95 | 78 | null | null | 1 | <2 mo. follow-up | 1 |
1,220 | 61.49197 | 0 | female | 0 | 39 | 715 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 270,064 | 81,985.25 | 78,320.625 | 26.25 | black | 24.097656 | 43 | 0.770996 | 0.696899 | 8 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 39 | 72 | 19.398438 | 115 | 34 | 38.5 | 292.5 | null | null | 1.699951 | 148 | 7.55957 | 110 | 71 | 1,118 | null | null | null | 2.164551 |
1,221 | 73.15796 | 1 | male | 0 | 8 | 12 | Lung Cancer | Cancer | 2 | null | null | 9 | 30,093 | 13,114.8672 | 12,471.5938 | 23 | white | 36.296875 | 45 | 0.131989 | 0.007 | 1 | 0 | 0 | metastatic | 0.1 | 0 | dnr after sadm | 1 | 71 | 31.398438 | 128 | 32 | 38.09375 | 347.5625 | 2.399902 | 1.299805 | 1.299805 | 134 | 7.469727 | 119 | 23 | 4,250 | null | null | <2 mo. follow-up | 4.350586 |
1,222 | 57.36099 | 1 | female | 0 | 4 | 16 | Lung Cancer | Cancer | 0 | 14 | $11-$25k | 0 | 7,234 | 3,338.7637 | 5,356.56641 | 9 | other | 17.199219 | 22 | 0.721924 | 0.445984 | 1 | 0 | 0 | metastatic | 0.5 | 0.1 | dnr after sadm | 1 | 109 | 4.399414 | 96 | 28 | 36.39844 | null | null | null | null | 140 | null | null | null | 600 | 5 | 5 | <2 mo. follow-up | 5 |
1,223 | 49.72998 | 0 | female | 0 | 34 | 710 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 9 | 225,448 | 85,349.9375 | 91,578 | 40.5 | white | 41.898438 | 82 | 0.459961 | 0.340942 | 1 | 0 | 0 | no | 0.3 | 0.3 | dnr after sadm | 5 | 38 | 42.09375 | 140 | 24 | 38.09375 | 193.3125 | 1.5 | 0.599976 | 7 | 134 | 7.369141 | 173 | 147 | 4,625 | 5 | 6 | adl>=4 (>=5 if sur) | 6 |
1,224 | 70.12994 | 1 | male | 0 | 7 | 275 | CHF | COPD/CHF/Cirrhosis | 3 | 16 | >$50k | 0 | 24,386 | 9,793.1484 | 10,982.7266 | 15 | white | 20.597656 | 41 | 0.838989 | 0.735962 | 1 | 1 | 0 | no | 0.5 | 0.2 | no dnr | 7 | 58 | 9.398438 | 105 | 20 | 36.69531 | null | null | 0.5 | 1.699951 | 136 | null | 361 | 41 | 3,780 | 1 | 1 | no(M2 and SIP pres) | 1 |
1,225 | 61.79898 | 1 | male | 0 | 71 | 194 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | under $11k | 0 | 286,496 | 147,557.75 | 111,358.938 | 19 | white | 37.59375 | 46 | 0.559937 | 0.363953 | 1 | 0 | 0 | no | 0.2 | 0.1 | no dnr | 71 | 38 | 11.398438 | 105 | 22 | 36.09375 | null | null | null | 1.799805 | 133 | null | null | 52 | 2,800 | null | null | no(M2 and SIP pres) | 3.345215 |
1,226 | 47.896 | 1 | female | 1 | 20 | 20 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 18 | >$50k | 100 | null | 70,495.6875 | 75,194.625 | 41.666657 | white | 32.296875 | 38 | 0.171997 | 0.08699 | 16 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 19 | 113 | 11.798828 | 105 | 15 | 39.39844 | 168 | null | 9.199219 | 0.5 | 134 | 7.5 | null | 17 | 2,335 | null | 0 | <2 mo. follow-up | 0 |
1,227 | 52.129 | 0 | male | 0 | 12 | 708 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | $11-$25k | 0 | 36,250 | 17,748.6094 | 16,195.0234 | 22 | white | 25.898438 | 38 | 0.834961 | 0.72998 | 1 | 0 | 0 | no | 0.3 | 0.1 | no dnr | 12 | 47 | 10.599609 | 65 | 24 | 36.29688 | null | 4.299805 | 2.599609 | 2 | 134 | null | 105 | 24 | 2,445 | 0 | null | null | 0.494751 |
1,228 | 51.461 | 1 | female | 1 | 9 | 9 | Lung Cancer | Cancer | 3 | null | null | 9 | 38,782 | 15,543.375 | 15,952.2188 | 10.5 | white | 21.296875 | 49 | 0.612915 | 0.296997 | 1 | 0 | 0 | metastatic | null | null | dnr after sadm | 1 | 59 | 10 | 112 | 36 | 36.59375 | null | null | null | 1 | 141 | null | 112 | 14 | 350 | null | null | <2 mo. follow-up | 3.280273 |
1,229 | 59.95297 | 0 | male | 0 | 9 | 705 | Cirrhosis | COPD/CHF/Cirrhosis | 3 | 12 | $11-$25k | 0 | 37,026 | 16,442.4688 | 19,089.8125 | 16 | white | 27.199219 | 59 | 0.655884 | 0.47998 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 9 | 108 | 36.695313 | 130 | 28 | 37.89844 | null | 2.399902 | 0.599976 | 2.399902 | 142 | null | 122 | 71 | 510 | 1 | 2 | adl>=4 (>=5 if sur) | 2 |
1,230 | 77.29999 | 0 | female | 0 | 8 | 705 | Colon Cancer | Cancer | 1 | 12 | >$50k | 0 | 23,099 | 9,433.7266 | 9,360.38281 | 14.5 | white | 15.398438 | 16 | 0.816895 | 0.605957 | 1 | 0 | 0 | metastatic | 0.95 | 0.95 | no dnr | 8 | 71 | 13 | 72 | 14 | 36.19531 | null | 2.5 | 1 | 0.899902 | 140 | null | null | null | 1,050 | 0 | null | null | 0.494751 |
1,231 | 77.52496 | 1 | male | 1 | 19 | 19 | Coma | Coma | 2 | 10 | $11-$25k | 44 | 229,171 | 50,377.3438 | 54,639.8438 | 34.333313 | white | 33.398438 | 61 | 0.070999 | 0.038994 | 5 | 0 | 0 | no | 0.95 | 0.75 | dnr after sadm | 16 | 55 | 15.199219 | 105 | 32 | 35.29688 | 310 | null | 1 | 4.5 | 144 | 7.619141 | 151 | 123 | 302 | null | 1 | <2 mo. follow-up | 1 |
1,232 | 50.09399 | 1 | male | 0 | 22 | 155 | CHF | COPD/CHF/Cirrhosis | 2 | 13 | $25-$50k | 0 | 172,027 | 89,110.1875 | 70,792.625 | 32.666657 | white | 29 | 36 | 0.799927 | 0.677979 | 1 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 22 | 55 | 5.199219 | 75 | 20 | 36.09375 | null | null | null | 2.699707 | 126 | null | 140 | 38 | 2,000 | 0 | null | no(M2 and SIP pres) | 0.494751 |
1,233 | 43.53998 | 1 | female | 1 | 29 | 29 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | $25-$50k | 37 | 313,131 | 120,728.75 | 133,639.125 | 39.5 | white | 34.195313 | 63 | 0.575928 | 0.465942 | 1 | 0 | 0 | no | 0.5 | 0.05 | dnr after sadm | 23 | 78 | 24.597656 | 155 | 12 | 38 | 136 | null | 6.599609 | 0.599976 | 134 | 7.509766 | 210 | 28 | 1,675 | null | 0 | <2 mo. follow-up | 0 |
1,234 | 65.01794 | 0 | male | 0 | 55 | 704 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $11-$25k | 0 | 346,376 | 128,525.562 | 137,877.375 | 39 | white | 21 | 20 | 0.806885 | 0.74292 | 7 | 0 | 0 | no | 0.5 | 0.5 | no dnr | 55 | 108 | 7.799805 | 105 | 18 | 36.69531 | 127.26562 | 2.5 | 0.299988 | 1.099854 | 139 | 7.419922 | 93 | 17 | 5,930 | null | 1 | null | 1 |
1,235 | 75.55597 | 1 | female | 0 | 6 | 93 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $11-$25k | 26 | 128,893 | 15,698.1953 | 17,042.9688 | 42 | white | 24.597656 | 27 | 0.587891 | 0.478943 | 10 | 0 | 0 | no | 0.95 | 0.95 | no dnr | 6 | 68 | 15.298828 | 115 | 24 | 36.89844 | 200 | 2.599609 | null | 0.799927 | 131 | 7.5 | 155 | 25 | 2,165 | null | 0 | Coma or Intub | 0 |
1,236 | 61.76599 | 0 | female | 0 | 6 | 703 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 13 | null | 0 | 33,585 | 10,267.5391 | 12,295.6328 | 18 | black | 24.898438 | 29 | 0.730957 | 0.647949 | 3 | 1 | 0 | yes | 0.75 | 0.75 | no dnr | 6 | 84 | 6.799805 | 75 | 26 | 36.5 | 217.125 | null | 9 | 0.699951 | 134 | 7.439453 | null | 8 | 2,350 | null | 0 | null | 0 |
1,237 | 35.47198 | 1 | male | 1 | 28 | 28 | MOSF w/Malig | ARF/MOSF | 1 | 16 | $25-$50k | 26 | 687,411 | 126,430.312 | 131,994.875 | 44.5 | white | 46.898438 | 100 | 0.014 | 0.003 | 66 | 0 | 0 | yes | 0.1 | 0.1 | dnr after sadm | 10 | 55 | 0.599976 | 115 | 34 | 39.09375 | 142.5 | 1.699951 | 14 | 1.799805 | 147 | 7.469727 | 145 | 107 | 1,508 | null | null | <2 mo. follow-up | 2.510254 |
1,238 | 56.36697 | 1 | male | 1 | 6 | 6 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 6 | under $11k | 37 | 299,542 | 26,629.2344 | 27,638.9531 | 42 | hispanic | 43.195313 | 87 | 0.127991 | 0.057999 | 19 | 0 | 0 | no | 0.3 | 0.25 | dnr after sadm | 6 | 48 | 31.199219 | 105 | 30 | 38.5 | 168 | null | 10.099609 | 3 | 141 | 7.419922 | 170 | 73 | 0 | null | 0 | <2 mo. follow-up | 0 |
1,239 | 74.69995 | 0 | female | 0 | 17 | 700 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 11 | under $11k | 26 | 76,763 | 28,010.2344 | 26,750.9844 | 19.666656 | black | 26.199219 | 58 | 0.61499 | 0.509888 | 2 | 0 | 0 | no | null | null | dnr after sadm | 14 | 52 | 8.298828 | 65 | 36 | 36.79688 | 368.5 | null | null | 2.5 | 136 | 7.419922 | 98 | 48 | 1,000 | null | 1 | null | 1 |
1,240 | 46.09198 | 0 | female | 0 | 61 | 701 | MOSF w/Malig | ARF/MOSF | 2 | null | null | 26 | 545,065 | 176,415.5 | 165,700.25 | 31.25 | white | 43.09375 | 101 | 0.043999 | 0.012999 | 18 | 0 | 0 | yes | 0.2 | 0.1 | no dnr | 61 | 52 | 0.049995 | 165 | 24 | 37.69531 | 275.5 | null | 3.899902 | 3.5 | 146 | 7.359375 | 269 | 63 | 0 | null | null | null | 3.685547 |
1,241 | 53.27899 | 1 | female | 0 | 14 | 542 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 96,262 | 22,771.6094 | 23,174.8906 | 20.333328 | white | 22.5 | 26 | 0.716919 | 0.630981 | 4 | 0 | 0 | yes | 0.9 | 0.8 | no dnr | 14 | 123 | 12.199219 | 130 | 28 | 37.89844 | 337.75 | 3 | 0.5 | 1 | 132 | 7.329102 | 125 | 5 | 3,250 | null | null | null | 3.367676 |
1,242 | 53.06198 | 1 | female | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 471,833 | 111,073.875 | 126,851.562 | 44.333313 | asian | 36.398438 | 68 | 0.406982 | 0.287964 | 10 | 0 | 0 | no | 0.7 | 0.5 | no dnr | 24 | 63 | 4.899414 | 125 | 12 | 36.19531 | 177.5 | 3.699707 | 9.5 | 2.099609 | 142 | 7.299805 | 438 | 63 | 452 | null | null | <2 mo. follow-up | 2.624023 |
1,243 | 69.133 | 1 | male | 1 | 5 | 5 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 14 | $25-$50k | 44 | 57,562 | 18,690.7188 | 23,200.7031 | 51 | asian | 31.597656 | 44 | 0.381958 | 0.262939 | 4 | 0 | 1 | no | 0.1 | 0.1 | dnr after sadm | 4 | 68 | 5.399414 | 135 | 28 | 38.19531 | 80 | null | 0.599976 | 1.199951 | 133 | 7.459961 | 140 | 15 | 3,010 | null | 3 | <2 mo. follow-up | 3 |
1,244 | 54.46997 | 1 | male | 1 | 43 | 43 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 18 | >$50k | 26 | 658,861 | 176,627 | 180,428.125 | 43.25 | hispanic | 41.796875 | 83 | 0.243988 | 0.140991 | 9 | 1 | 0 | no | null | null | dnr after sadm | 42 | 58 | 7.299805 | 115 | 50 | 39.29688 | 116 | 3.099609 | 3.599609 | 2.5 | 163 | 7.419922 | 180 | 75 | 2,151 | null | null | <2 mo. follow-up | 3.080078 |
1,245 | 45.96298 | 1 | female | 1 | 10 | 10 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 14 | >$50k | 26 | 402,858 | 48,769.5625 | 49,616.7812 | 42 | white | 26.199219 | 39 | 0.692993 | 0.600952 | 25 | 0 | 0 | no | 0.8 | 0.8 | dnr after sadm | 9 | 118 | 4.099609 | 115 | 24 | 38 | 502.8125 | 2.699707 | 4.099609 | 1.699951 | 138 | 7.419922 | 186 | 120 | 2,110 | null | 3 | <2 mo. follow-up | 3 |
1,246 | 38.83099 | 1 | female | 1 | 18 | 18 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 13 | $25-$50k | 37 | 449,656 | 76,598.4375 | 81,414.4375 | 54.666657 | white | 54.398438 | 98 | 0.028999 | 0.007999 | 13 | 0 | 0 | no | 0.5 | 0.4 | dnr after sadm | 17 | 45 | 1.399902 | 180 | 18 | 39.5 | 106 | 1.899902 | 12.599609 | 1.599854 | 151 | 7.40918 | 161 | 86 | 3,590 | null | 0 | <2 mo. follow-up | 0 |
1,247 | 48.43799 | 0 | female | 0 | 18 | 693 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 12 | >$50k | 0 | 126,356 | 45,821.75 | 47,891.75 | 28.333328 | white | 25.296875 | 36 | 0.829956 | 0.771973 | 2 | 0 | 0 | no | 0.85 | 0.85 | no dnr | 18 | 122 | 16.199219 | 145 | 15 | 38 | 134 | 2.199707 | 0.299988 | 1.099854 | 145 | 7.319336 | 125 | 15 | 3,975 | null | 0 | null | 0 |
1,248 | 74.88794 | 0 | female | 0 | 26 | 692 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $11-$25k | 0 | 367,797 | 60,647.9375 | 64,849.3438 | 28.75 | white | 25.699219 | 36 | 0.656982 | 0.55896 | 20 | 0 | 0 | no | 0.65 | 0.65 | dnr after sadm | 12 | 68 | 13 | 110 | 36 | 38.39844 | 167.5 | 3.199707 | 1.599854 | 0.899902 | 148 | 7.389648 | 178 | 37 | 2,360 | null | 1 | adl>=4 (>=5 if sur) | 1 |
1,249 | 68.08795 | 0 | male | 0 | 69 | 692 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 18 | null | 0 | 543,761 | null | null | 45.25 | white | 29.796875 | 53 | 0.633911 | 0.530884 | 6 | 0 | 0 | no | 0.8 | 0.8 | no dnr | 69 | 67 | 18.097656 | 75 | 12 | 36.59375 | 186.65625 | null | 2.399902 | 5 | 129 | 7.489258 | 221 | 63 | 20 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,250 | 27.30199 | 0 | female | 0 | 16 | 691 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 26 | 147,320 | 44,378.1875 | 43,762.8125 | 26.333328 | hispanic | 23.597656 | 22 | 0.841919 | 0.787964 | 4 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 16 | 98 | 15.599609 | 105 | 48 | 36.79688 | 197.9375 | null | 0.699951 | 1.199951 | 135 | 7.419922 | 177 | 22 | 3,405 | null | null | null | 3.547363 |
1,251 | 64.66296 | 0 | female | 0 | 25 | 690 | CHF | COPD/CHF/Cirrhosis | 2 | 15 | $11-$25k | 0 | 82,891 | 35,861.9375 | 35,270.2188 | 20.75 | white | 28.898438 | 46 | 0.737915 | 0.587891 | 1 | 0 | 0 | no | 0.6 | 0.5 | no dnr | 25 | 58 | 12.199219 | 145 | 26 | 36.19531 | null | 2.899902 | 0.699951 | 1 | 129 | null | 92 | 13 | 1,265 | 0 | null | null | 0.494751 |
1,252 | 74.47998 | 0 | male | 0 | 16 | 689 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | null | 0 | 43,115 | 22,599.7812 | 17,989.2656 | 22.333328 | hispanic | 17.898438 | 24 | 0.855957 | 0.762939 | 1 | 0 | 0 | no | null | null | no dnr | 16 | 73 | 7.5 | 70 | 28 | 36 | null | null | null | 1.399902 | 142 | null | 87 | 22 | 3,450 | 4 | 0 | no(M2 and SIP pres) | 0 |
1,253 | 56.96597 | 1 | male | 1 | 36 | 36 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 743,890 | 136,667.25 | 141,648.125 | 42.5 | white | 43.296875 | 77 | 0.089996 | 0.035995 | 62 | 0 | 0 | yes | 0.1 | 0 | dnr after sadm | 35 | 53 | 18.796875 | 115 | 22 | 39.5 | 200 | null | 24.199219 | 3.899902 | 137 | 7.549805 | 97 | 72 | 180 | null | null | <2 mo. follow-up | 2.800293 |
1,254 | 68.32599 | 0 | male | 0 | 7 | 687 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 19 | >$50k | 0 | 19,224 | 7,768.3281 | 7,791.80859 | 7.5 | white | 21.296875 | 28 | 0.832886 | 0.775879 | 1 | 0 | 0 | no | 0.95 | 0.9 | no dnr | 7 | 105 | 10.798828 | 100 | 30 | 37.79688 | null | null | null | 1.199951 | 130 | null | 247 | 21 | 3,350 | 0 | null | no(M2 and SIP pres) | 0.494751 |
1,255 | 64.02997 | 1 | male | 1 | 30 | 30 | CHF | COPD/CHF/Cirrhosis | 2 | 12 | >$50k | 0 | 193,563 | 70,496.6875 | 71,872.875 | 31.25 | white | 25.796875 | 36 | 0.791992 | 0.665894 | 1 | 0 | 0 | no | null | null | dnr after sadm | 28 | 62 | 4.5 | 65 | 22 | 36.5 | 173.3125 | null | 3 | 2.099609 | 132 | 7.469727 | 110 | 34 | 3,465 | 1 | 0 | <2 mo. follow-up | 0 |
1,256 | 56.01898 | 1 | male | 0 | 60 | 318 | ARF/MOSF w/Sepsis | ARF/MOSF | 5 | 14 | $25-$50k | 41 | null | null | null | 34.25 | hispanic | 27.699219 | 50 | 0.540894 | 0.426941 | 18 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 60 | 112 | 7.299805 | 115 | 26 | 38.39844 | null | 2.899902 | 4.799805 | 2.799805 | 136 | null | 168 | 104 | 1,000 | null | 7 | null | 7 |
1,257 | 56.42697 | 1 | female | 1 | 60 | 60 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 12 | $25-$50k | 0 | null | 196,988.875 | 208,260.125 | 48 | white | 31.398438 | 60 | 0.56897 | 0.457947 | 11 | 0 | 0 | yes | 0.7 | 0.68 | dnr after sadm | 55 | 128 | 23.199219 | 160 | 28 | 38.89844 | 88.5625 | null | 1 | 1.199951 | 145 | 7.40918 | 292 | 80 | 3,495 | null | 0 | null | 0 |
1,258 | 74.97296 | 0 | female | 0 | 4 | 684 | CHF | COPD/CHF/Cirrhosis | 4 | 9 | under $11k | 0 | 5,306 | 3,045.7793 | 2,876.6582 | 12 | black | 17.398438 | 24 | 0.860962 | 0.769897 | 1 | 0 | 0 | no | 0.95 | 0.75 | no dnr | 4 | 101 | 3.799805 | 76 | 20 | 36.39844 | null | null | null | 1.899902 | 141 | null | null | 39 | 1,670 | 6 | null | null | 4.527344 |
1,259 | 66.64197 | 1 | female | 0 | 15 | 181 | Lung Cancer | Cancer | 1 | 10 | null | 0 | 55,841 | 23,905.6562 | 25,365.6094 | 21.666656 | white | 33.5 | 48 | 0.260986 | 0.035995 | 1 | 0 | 0 | metastatic | null | null | no dnr | 15 | 46 | 8.898438 | 160 | 32 | 36 | null | 3.399902 | 0.399963 | 0.599976 | 139 | null | 128 | 6 | 1,075 | 0 | null | null | 0.494751 |
1,260 | 37.25699 | 1 | male | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 6 | 10 | under $11k | 0 | 188,152 | 63,810.8438 | 66,264.5 | 59 | hispanic | 51.09375 | 82 | 0.153992 | 0.074997 | 8 | 0 | 0 | yes | 0.25 | 0.1 | dnr after sadm | 11 | 65 | 9.898438 | 100 | 42 | 34.89844 | 87.5 | null | 31.5 | 4.199219 | 146 | 7.429688 | 152 | 75 | 847 | null | 0 | <2 mo. follow-up | 0 |
1,261 | 59.70697 | 1 | female | 1 | 12 | 12 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 12 | null | 44 | 770,591 | 59,998.0625 | 60,779.1875 | 42.5 | white | 34.695313 | 53 | 0.273987 | 0.166992 | 80 | 0 | 0 | no | 0.5 | 0.3 | dnr after sadm | 9 | 58 | 3.099609 | 125 | 35 | 39.5 | 110 | null | 0.799927 | 1.099854 | 139 | 7.5 | null | 35 | 3,805 | null | 4 | <2 mo. follow-up | 4 |
1,262 | 57.91397 | 1 | female | 0 | 34 | 95 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 376,476 | 77,035.1875 | 83,668.4375 | 37.75 | white | 26.796875 | 41 | 0.725952 | 0.641968 | 14 | 0 | 0 | no | 0.7 | 0.65 | no dnr | 34 | 120 | 23 | 125 | 12 | 37.59375 | 130 | null | null | 1.199951 | 136 | 7.449219 | 294 | 40 | 2,770 | null | 2 | adl>=4 (>=5 if sur) | 2 |
1,263 | 79.81396 | 1 | male | 0 | 7 | 351 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | $25-$50k | 37 | 181,788 | 20,369.375 | 22,665.5156 | 34.5 | white | 42.398438 | 55 | 0.063995 | 0.021999 | 7 | 0 | 0 | no | 0.35 | 0.35 | no dnr | 7 | 45 | 16 | 95 | 48 | 39.5 | 133.3125 | null | 6.299805 | 1.199951 | 152 | 7.479492 | 165 | 50 | 2,496 | null | 0 | adl>=4 (>=5 if sur) | 0 |
1,264 | 80.49298 | 0 | male | 0 | 9 | 681 | CHF | COPD/CHF/Cirrhosis | 2 | 15 | $25-$50k | 0 | 27,792 | 14,040.6328 | 11,944.5469 | 10 | white | 15.199219 | 17 | 0.86792 | 0.780884 | 1 | 0 | 0 | no | 0.7 | 0.343 | no dnr | 9 | 78 | 16.097656 | 85 | 28 | 38.19531 | 217.5 | null | null | 0.799927 | 133 | 7.429688 | 115 | 10 | 1,925 | null | null | null | 2.354981 |
1,265 | 63.56198 | 1 | female | 0 | 8 | 27 | COPD | COPD/CHF/Cirrhosis | 3 | 12 | under $11k | 0 | 56,383 | 19,704.25 | 20,505.7812 | 28.5 | black | 33.796875 | 63 | 0.654907 | 0.477966 | 1 | 0 | 0 | no | 0.9 | 0.85 | no dnr | 8 | 85 | 7.699219 | 72 | 24 | 36.5 | null | null | null | 1.399902 | 142 | null | 112 | 24 | 1,215 | null | 0 | <2 mo. follow-up | 0 |
1,266 | 89.92499 | 1 | male | 1 | 3 | 3 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 41 | 215,263 | 16,649.3125 | 17,978.9844 | 44 | asian | 35 | 69 | 0.122986 | 0.054993 | 14 | 0 | 0 | no | 0.7 | 0.4 | no dnr | 3 | 58 | 22.699219 | 145 | 32 | 36.29688 | 227.5 | 3.299805 | 0.399963 | 2.699707 | 131 | 7.399414 | 147 | 51 | 1,880 | null | null | <2 mo. follow-up | 3.8125 |
1,267 | 75.64996 | 0 | female | 0 | 4 | 677 | Lung Cancer | Cancer | 1 | null | null | 0 | 9,252 | 3,596.1035 | 4,376.90625 | 13 | white | 13.798828 | 13 | 0.743896 | 0.480957 | 1 | 0 | 0 | metastatic | null | null | no dnr | 4 | 60 | 17.097656 | 5 | 30 | 37.59375 | 305 | 2.299805 | 4.5 | 2.599609 | 138 | 7.319336 | null | 60 | 13 | null | null | null | 2.349121 |
1,268 | 52.33398 | 0 | female | 0 | 15 | 677 | CHF | COPD/CHF/Cirrhosis | 3 | 14 | under $11k | 0 | 44,858 | 23,246.25 | 19,415.0938 | 21 | white | 24.199219 | 35 | 0.852905 | 0.757935 | 1 | 1 | 0 | no | 0.8 | 0.6 | no dnr | 15 | 71 | 5.5 | 80 | 24 | 36.59375 | null | null | null | 0.899902 | 139 | null | null | 17 | null | 0 | null | null | 0.494751 |
1,269 | 41.21298 | 1 | female | 0 | 7 | 145 | Lung Cancer | Cancer | 1 | 14 | $25-$50k | 0 | 17,155 | 7,595.1016 | 10,415.9141 | 5 | white | 18.398438 | 22 | 0.734985 | 0.46698 | 1 | 0 | 0 | metastatic | 0.6 | 0.3 | dnr after sadm | 1 | 45 | 5.5 | 75 | 18 | 36 | null | 3.899902 | 0.5 | 1.599854 | 135 | null | 186 | 21 | 1,700 | null | 3 | adl>=4 (>=5 if sur) | 3 |
1,270 | 62.60898 | 1 | female | 0 | 9 | 471 | Lung Cancer | Cancer | 2 | 12 | $11-$25k | 0 | 36,914 | 15,720.0781 | 16,989.625 | 13.5 | white | 18.398438 | 10 | 0.684937 | 0.391968 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 9 | 71 | 5.599609 | 76 | 20 | 36.39844 | null | null | 2 | 0.599976 | 133 | null | 93 | 4 | 1,850 | null | null | no(M2 and SIP pres) | 3.484375 |
1,271 | 71.47198 | 1 | male | 0 | 7 | 122 | CHF | COPD/CHF/Cirrhosis | 2 | 18 | >$50k | 0 | 22,851 | 11,544.6016 | 9,719.5625 | 17 | white | 32 | 44 | 0.634888 | 0.452942 | 1 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 7 | 109 | 6.899414 | 104 | 22 | 36.39844 | 460 | null | null | 0.899902 | 134 | 7.399414 | 183 | null | 2,075 | null | 2 | null | 2 |
1,272 | 43.129 | 1 | female | 0 | 9 | 380 | Lung Cancer | Cancer | 1 | null | null | 0 | 32,776 | 15,275.6172 | 15,465.8125 | 12.5 | white | 13.199219 | 11 | 0.813965 | 0.599976 | 1 | 0 | 0 | metastatic | 1 | 0.75 | no dnr | 9 | 49 | 3.799805 | 65 | 20 | 36.29688 | null | null | null | 2.199707 | 126 | null | null | 71 | 1,575 | null | null | null | 2.930664 |
1,273 | 45.16098 | 1 | male | 1 | 5 | 5 | Coma | Coma | 0 | 12 | under $11k | 100 | 47,000 | 16,881.7812 | 21,055.7656 | 48 | white | 30.5 | 48 | 0.218994 | 0.155975 | 1 | 0 | 0 | no | 0.1 | 0.1 | dnr after sadm | 4 | 73 | null | 80 | 16 | 38.19531 | null | null | null | 0.699951 | 140 | null | 87 | 10 | 2,375 | null | 0 | <2 mo. follow-up | 0 |
1,274 | 55.76498 | 1 | female | 0 | 14 | 109 | MOSF w/Malig | ARF/MOSF | 1 | 20 | $25-$50k | 0 | 84,742 | 36,031.0312 | 36,630.8438 | 21.333328 | white | 35.296875 | 38 | 0.42395 | 0.303955 | 1 | 0 | 0 | yes | 0.7 | 0.5 | no dnr | 14 | 132 | 22.597656 | 135 | 20 | 38.59375 | 148.875 | 3.399902 | 0.399963 | 2.399902 | 148 | 7.359375 | 401 | 47 | 3,975 | null | null | null | 2.979492 |
1,275 | 70.12695 | 1 | male | 1 | 9 | 9 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 16 | null | 26 | 93,405 | 33,662.875 | 40,258.8125 | 59 | white | 23.898438 | 38 | 0.710938 | 0.622925 | 1 | 0 | 0 | no | 0.3 | 0.3 | dnr after sadm | 8 | 62 | 4.599609 | 135 | 38 | 39.39844 | 83.32812 | null | 0.799927 | 0.699951 | 146 | 7.339844 | null | 25 | 2,095 | null | 2 | <2 mo. follow-up | 2 |
1,276 | 70.20697 | 1 | male | 0 | 59 | 121 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | null | null | 55 | 480,909 | 147,843.125 | 135,322.875 | 35 | white | 25.199219 | 37 | 0.481995 | 0.362976 | 7 | 1 | 0 | no | 0.3 | 0.3 | no dnr | 59 | 68 | 17.898438 | 145 | 24 | 36.69531 | 222.84375 | 2.599609 | 0.5 | 0.799927 | 131 | 7.439453 | 235 | 32 | 4,750 | null | 4 | Coma or Intub | 4 |
1,277 | 65.87299 | 1 | female | 1 | 22 | 22 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | 9 | under $11k | 26 | 349,615 | 61,846.9062 | 68,313.375 | 38.666657 | white | 28.796875 | 50 | 0.524902 | 0.408997 | 15 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 14 | 115 | 4.599609 | 65 | 26 | 36 | 482.5 | 2.5 | 3.399902 | 1.599854 | 142 | 7.459961 | 253 | 66 | 2,395 | null | 1 | <2 mo. follow-up | 1 |
1,278 | 37.77399 | 1 | female | 0 | 28 | 93 | Lung Cancer | Cancer | 1 | 14 | >$50k | 0 | 124,501 | 49,427.8438 | 50,069.2812 | 22.75 | white | 11.199219 | 13 | 0.846924 | 0.662964 | 1 | 0 | 0 | metastatic | 0.8 | 0.5 | no dnr | 28 | 73 | 5.399414 | 115 | 36 | 38.39844 | 225 | null | null | 5.5 | 149 | 7.439453 | 234 | 125 | 1,400 | null | 0 | null | 0 |
1,279 | 27.866 | 0 | female | 0 | 10 | 670 | CHF | COPD/CHF/Cirrhosis | 2 | 18 | $25-$50k | 0 | 34,964 | 17,250.1562 | 16,624.7656 | 19.5 | white | 15 | 20 | 0.956909 | 0.92688 | 1 | 0 | 0 | no | 0.95 | 0.7 | no dnr | 10 | 69 | 7.199219 | 74 | 20 | 37.89844 | null | 3.599609 | 0.399963 | 1 | 135 | null | 84 | 5 | 7,025 | 1 | 2 | null | 2 |
1,280 | 46.51898 | 1 | male | 0 | 107 | 110 | CHF | COPD/CHF/Cirrhosis | 4 | 14 | null | 26 | 466,224 | 232,577.375 | 203,412.75 | 24 | hispanic | 40.5 | 71 | 0.46698 | 0.264954 | 1 | 1 | 0 | no | 0.25 | 0.25 | no dnr | 107 | 67 | 9.5 | 105 | 20 | 36.19531 | null | 4.199219 | 1 | 1.399902 | 140 | null | 80 | 17 | 900 | null | 0 | null | 0 |
1,281 | 75.461 | 1 | female | 0 | 5 | 451 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 22,979 | 9,299.4453 | 9,028.52344 | 31 | black | 17 | 22 | 0.862915 | 0.773926 | 1 | 0 | 0 | no | 0.8 | 0.7 | no dnr | 5 | 56 | 7.899414 | 105 | 8 | 36 | 228.875 | 2.799805 | 9.5 | 2.299805 | 155 | 7.459961 | 184 | 59 | 1,965 | null | null | null | 3.364258 |
1,282 | 66.50494 | 1 | male | 1 | 127 | 127 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | null | null | 26 | 983,206 | null | null | 43 | white | 42.898438 | 84 | 0.22699 | 0.127991 | 1 | 0 | 0 | no | 0.95 | 0.65 | dnr after sadm | 31 | 114 | 7.099609 | 70 | 30 | 36.59375 | 211.09375 | null | null | 0.899902 | 145 | 7.339844 | 102 | 18 | 5,650 | null | null | Coma or Intub | 2.810547 |
1,283 | 49.89697 | 1 | female | 0 | 71 | 308 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 12 | under $11k | 0 | 550,783 | 250,646 | 225,433.625 | 28.75 | black | 32.195313 | 36 | 0.73291 | 0.649902 | 1 | 0 | 0 | no | null | null | no dnr | 71 | 45 | 23.199219 | 170 | 10 | 38.39844 | 100 | null | null | 2.299805 | 134 | 7.319336 | 287 | 33 | 279 | 3 | 0 | adl>=4 (>=5 if sur) | 0 |
1,284 | 45.08698 | 1 | male | 1 | 7 | 7 | ARF/MOSF w/Sepsis | ARF/MOSF | 4 | 18 | null | 44 | 385,690 | 26,342.0469 | 24,456.8906 | 36.5 | asian | 39.195313 | 84 | 0.252991 | 0.148987 | 37 | 1 | 0 | no | 0.05 | 0.05 | dnr after sadm | 5 | 77 | 15.898438 | 80 | 20 | 36.29688 | null | null | 20.597656 | 2.199707 | 131 | null | 76 | 11 | 2,250 | null | null | <2 mo. follow-up | 3.789063 |
1,285 | 71.849 | 0 | male | 0 | 8 | 667 | CHF | COPD/CHF/Cirrhosis | 3 | null | null | 0 | 64,436 | 12,104.5703 | 12,397.8047 | 23 | white | 28.898438 | 39 | 0.626953 | 0.442993 | 9 | 0 | 0 | no | 0.3 | 0.3 | no dnr | 8 | 50 | 9.298828 | 25 | 28 | 38.5 | 295 | null | 9.5 | 2.5 | 136 | 7.279297 | null | 89 | 1,790 | null | null | null | 2.848633 |
1,286 | 56.88199 | 1 | female | 1 | 4 | 4 | MOSF w/Malig | ARF/MOSF | 3 | null | null | 26 | 25,415 | 9,614.6406 | 12,402.25 | 37 | white | 30.199219 | 31 | 0.436951 | 0.316956 | 1 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 4 | 49 | 12.398438 | 135 | 16 | 36.69531 | 211 | null | null | 1.199951 | 137 | 7.089844 | null | 18 | 3,013 | null | null | <2 mo. follow-up | 2.995117 |
1,287 | 39.02298 | 1 | female | 1 | 24 | 24 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 0 | 288,218 | 98,932.75 | 108,947.312 | 53.333313 | black | 39.195313 | 74 | 0.588989 | 0.47998 | 4 | 0 | 0 | no | 0.1 | 0.01 | dnr after sadm | 18 | 78 | 25.796875 | 120 | 32 | 36.5 | 469.375 | null | null | 0.5 | 127 | 7.479492 | null | 13 | 3,765 | null | 2 | <2 mo. follow-up | 2 |
1,288 | 56.10999 | 1 | male | 1 | 27 | 27 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 55 | 419,661 | 141,917.875 | 155,250.5 | 47.75 | white | 29.296875 | 77 | 0.472961 | 0.353943 | 5 | 0 | 0 | no | 0.5 | 0.5 | dnr after sadm | 26 | 113 | 0.099991 | 135 | 12 | 35.79688 | 265.25 | 1.799805 | 7.5 | 1.299805 | 131 | 7.299805 | 617 | 30 | 3,580 | null | null | <2 mo. follow-up | 2.902832 |
1,289 | 66.26398 | 0 | female | 0 | 12 | 666 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 37 | 210,275 | 30,875.0625 | 32,321.875 | 35 | asian | 21.699219 | 21 | 0.659912 | 0.56189 | 11 | 0 | 0 | no | 0.85 | 0.85 | no dnr | 12 | 57 | 22.199219 | 100 | 31 | 38.5 | 182 | null | 2.799805 | 8.099609 | 141 | 7.389648 | 513 | 87 | 12 | null | null | null | 2.475098 |
1,290 | 67.92596 | 1 | female | 1 | 14 | 14 | MOSF w/Malig | ARF/MOSF | 1 | null | null | 44 | 320,408 | 67,552.125 | 63,066.0625 | 35.333313 | white | 47.898438 | 78 | 0.001 | 0 | 35 | 0 | 0 | yes | 0.1 | 0.05 | dnr after sadm | 12 | 100 | 16.796875 | 110 | 10 | 39 | null | null | 1 | 0.599976 | 135 | null | 110 | 25 | 2,305 | null | null | <2 mo. follow-up | 2.764648 |
1,291 | 82.02594 | 1 | male | 0 | 26 | 311 | ARF/MOSF w/Sepsis | ARF/MOSF | 3 | null | null | 0 | 122,708 | 45,664.9062 | 48,383.5312 | 23.75 | white | 30.597656 | 63 | 0.600952 | 0.493958 | 1 | 0 | 0 | no | 0.5 | 0.125 | no dnr | 26 | 63 | 9.099609 | 108 | 8 | 37.89844 | 313.3125 | null | null | 0.899902 | 138 | 7.479492 | 107 | 25 | 1,800 | null | null | Coma or Intub | 3.472656 |
1,292 | 55.13797 | 0 | male | 0 | 9 | 663 | Lung Cancer | Cancer | 3 | 14 | null | 0 | 29,367 | 11,812.4141 | 13,211.5 | 14.5 | white | 9.298828 | 14 | 0.844971 | 0.659912 | 1 | 0 | 0 | metastatic | 1 | 1 | no dnr | 9 | 48 | 0.5 | 140 | 34 | 39.79688 | 120 | null | null | 0.799927 | 157 | 7.379883 | null | 24 | 3,935 | null | 0 | null | 0 |
1,293 | 38.771 | 0 | male | 0 | 4 | 661 | ARF/MOSF w/Sepsis | ARF/MOSF | 1 | 13 | $25-$50k | 0 | 27,652 | 6,754.5781 | 9,067.78906 | 16 | white | 23 | 22 | 0.878906 | 0.835938 | 2 | 0 | 0 | no | 0.8 | 0.75 | no dnr | 4 | 55 | 18.097656 | 175 | 31 | 36 | 260 | null | null | 1.799805 | 137 | 7.469727 | 179 | 50 | 1,337 | null | null | no(M2 and SIP pres) | 2.138672 |
1,294 | 23.76999 | 1 | female | 0 | 6 | 37 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | 16 | $11-$25k | 9 | 54,663 | 14,430.6406 | 17,988.7344 | 44 | hispanic | 42.5 | 55 | 0.586914 | 0.477966 | 2 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 6 | 70 | 10.599609 | 96 | 20 | 37.59375 | 309.5 | 4.099609 | 0.299988 | 0.799927 | 135 | 7.429688 | 126 | 11 | 2,890 | null | 0 | <2 mo. follow-up | 0 |
1,295 | 36.67398 | 1 | male | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 89 | 288,912 | 27,184.0625 | 23,017.6094 | 63 | black | 63.398438 | 121 | 0 | 0 | 9 | 0 | 0 | no | 0.9 | 0.9 | no dnr | 4 | 103 | 5 | 120 | 34 | 39 | null | 2.699707 | null | 0.799927 | 143 | null | null | 14 | 2,616 | null | null | <2 mo. follow-up | 2.575684 |
1,296 | 89.82599 | 1 | female | 1 | 4 | 4 | ARF/MOSF w/Sepsis | ARF/MOSF | 0 | null | null | 26 | 22,772 | 8,908.125 | 10,100.0469 | 31 | white | 42.296875 | 74 | 0.107986 | 0.045998 | 1 | 0 | 0 | no | 0.3 | 0.2 | dnr after sadm | 3 | 77 | 16.398438 | 118 | 28 | 36.19531 | 233.3125 | null | 0.699951 | 1.099854 | 133 | 7.469727 | 269 | 15 | 1,075 | null | null | <2 mo. follow-up | 3.566895 |
1,297 | 71.06396 | 0 | male | 0 | 15 | 656 | ARF/MOSF w/Sepsis | ARF/MOSF | 2 | 12 | $25-$50k | 0 | 88,606 | 28,624.5312 | 27,797.0938 | 26.666656 | white | 16.699219 | 35 | 0.843994 | 0.790894 | 7 | 0 | 0 | no | 0.75 | 0.6 | no dnr | 15 | 40 | 13.298828 | 115 | 36 | 38.79688 | 125 | null | null | 1.599854 | 143 | 7.519531 | null | 29 | 1,920 | 1 | 1 | null | 1 |
1,298 | 84.46796 | 1 | female | 1 | 3 | 3 | Coma | Coma | 2 | 10 | under $11k | 100 | 9,740 | 4,209.6055 | 4,440.21875 | 17 | black | 27.699219 | 78 | 0.024998 | 0.011 | 1 | 0 | 1 | no | 0.05 | 0 | dnr after sadm | 1 | 63 | 13.798828 | 168 | 40 | 39.59375 | 178.3125 | 1.699951 | 0.799927 | 0.699951 | 149 | 7.439453 | 147 | 32 | 2,710 | null | null | <2 mo. follow-up | 5.763672 |
1,299 | 93.46997 | 0 | female | 0 | 6 | 654 | CHF | COPD/CHF/Cirrhosis | 3 | 12 | >$50k | 0 | 13,705 | 7,081.7773 | 5,865.94922 | 17 | white | 21.699219 | 38 | 0.664917 | 0.490967 | 1 | 0 | 0 | yes | 0.7 | 0.6 | dnr after sadm | 2 | 59 | 13.099609 | 68 | 24 | 38.19531 | 90.76562 | null | null | 1.599854 | 142 | 7.469727 | 124 | 47 | 1,750 | 0 | 0 | SIP>=30 | 0 |
1,300 | 57.48898 | 1 | male | 1 | 4 | 4 | Cirrhosis | COPD/CHF/Cirrhosis | 5 | null | null | 0 | 49,892 | 19,744.2812 | 23,346.25 | 51 | white | 49.5 | 93 | 0.046997 | 0.004999 | 1 | 0 | 0 | yes | 0 | 0 | dnr after sadm | 3 | 35 | 33.09375 | 155 | 30 | 38.59375 | 65 | null | 17.5 | 4.199219 | 135 | 7.109375 | 151 | 48 | 34 | null | null | <2 mo. follow-up | 3.341797 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.